About

ABSTRACT FROM THE MEMORANDUM AND ARTICLES OF ASSOCIATION
SOCIETY FOR THE STUDY OF ANDROGEN DEFICIENCY IN THE ADULT MALE

THE COMPANIES ACTS 1985 AND 1989

COMPANY LIMITED BY GUARANTEE AND NOT HAVING A SHARE CAPITAL

MEMORANDUM OF ASSOCIATION OF

SOCIETY FOR THE STUDY OF ANDROGEN DEFICIENCY
(THE ANDROPAUSE SOCIETY)

1. The company’s name is the Society for the Study of Androgen Deficiency (The Andropause Society) (hereinafter called “the Society”).

2. The Society’s registered office is to be situated in England and Wales.

3. The Society’s objects are:

	(1) advancement of education and training in the medical understanding and treatment of androgen deficiency;
	(2) the relief of sickness, in particular, of the short and long term consequences of androgen deficiency;
	(3) the protection and preservation of public health, in particular, the health of the ageing population.

In furtherance of such objects but not further or otherwise, the Society shall have the power:-

	(i) to facilitate the advancement of education by the promotion of interest in all matters relating to the short and long term consequences of androgen deficiency and the associated life events;
	(ii) to facilitate the multi-disciplinary study of matters relating to androgen deficiency and the exchange of information and ideas between persons and organisations working in this field, as well as to provide an authoritative information resource for the general public via the internet and other media;
	(iii) to create an international network of health professionals willing to increase awareness of and investigate, treat and prevent androgen deficiency and its consequences and promote high standards of training in this field;
	(iv) to support the World Health Organisation in its efforts to alleviate the problems raised by the predicted increases in the over-sixties population;
	(v) to facilitate studies into prostate carcinoma and the need to clarify any possible links with testosterone levels;
	(vi) to foster and promote research relating to androgen deficiency in the adult male.